Loading…
← CockpitCompetitor Analysis › YATHARTH.NS Yatharth Hospital and Trauma Care Services LimitedOpen in the cockpit ↗

Yatharth Hospital and Trauma Care Services LimitedYATHARTH.NSCompetitor analysis, valuation and peers

India · INR·Pharma & Healthcare›Hospital/Nursing Management

Multi-specialty hospital chain operating in Delhi NCR and Uttar Pradesh, offering tertiary and quaternary care.

Momentum leader 91
Mkt cap
$1.13B
US dollars, full cap
Free float
43%
of shares outstanding
$/day
$3.45M
20-day average traded
Fwd P/E
49.4×
forward earnings
ROIC−WACC
-5.7 pp
WACC 14.0%
Hurdle
n/a
no reverse DCF
Next earnings
79 days
5 Feb 2027
Close · INR₹1,091
1D-1.7%
1W+4.6%
1M+12.4%
3M+27.8%
6M+31.0%
YTD+60.0%
1Y+47.4%
ATR %3.6%
Beta0.84
52w lowhigh7.8% off high

What Yatharth Hospital and Trauma Care Services does

Multi-specialty hospital chain operating in Delhi NCR and Uttar Pradesh, offering tertiary and quaternary care.

Products and services

  • Multi-specialty tertiary care
  • Renal sciences/transplant
  • Oncology care

Customers

  • Domestic patients in NCR/Uttar Pradesh

Where it sits in the supply chain

  • Healthcare services
  • Hospital/tertiary care
  • Regional multi-specialty hospital chain

What could go right

  • NCR/UP tertiary-care demand growth
  • Bed capacity expansion

What could go wrong

  • Regional concentration risk
  • Capex/leverage for expansion

Moat: none (installed base). Growing regional hospital network but limited differentiation versus larger established chains.

Headquarters: Noida, India · Founded: 2008 · Employees: 7,472

Named competitors

Yatharth Hospital and Trauma Care Services at a glance

Size Yatharth Hospital and Trauma Care Services (YATHARTH.NS) is an India Health Care company (Hospital/Nursing Management) with a market value of $1.13B, the 565th largest of 1,066 India companies the cockpit tracks. Shares closed at ₹1,091 on 18 Nov 2026.

Performance Over six months the shares gained 31.0%, against -3.8% for the median peer and +3.8% for the India market (cap-weighted) — 2nd highest of 20 in its peer set.

Growth Revenue grew 50.4% over the last twelve months (peer median +11.9%); the operating margin is 15.7% (peer median 10.0%).

Valuation It trades at 49.4× forward earnings against a peer median of 27.1× (4th most expensive of 16).

Capital Return on invested capital runs 5.7 points below its cost of capital (14.0% WACC).

Next results Next results expected around 5 Feb 2027 (exchange calendar; dates can move).

Relative performance

10012014021 May 202621 Aug 202618 Nov 2026YATHARTH.NS 129Peer median 94
Six months, rebased to 100: Yatharth Hospital and Trauma Care Services against the median of its 20 peers (local-currency closes).

Yatharth Hospital and Trauma Care Services financials

Reported figures in INR; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue₹14.9B₹12.0B₹8.86B₹6.71B₹5.20B
Revenue growth—+36%+32%+29%—
Gross profit₹8.03B₹3.48B₹2.74B₹2.53B₹2.02B
EBITDA₹3.48B₹3.06B₹2.33B₹1.84B₹1.36B
Net income₹1.91B₹1.75B₹1.31B₹1.14B₹658M
Free cash flown/a-₹957M-₹1.70B-₹933M₹227M
Capital expendituren/a₹3.17B₹3.02B₹934M₹198M
Total debt₹4.68B₹2.64B₹116M₹846M₹2.67B

Quarterly statements and history in the cockpit →

Yatharth Hospital and Trauma Care Services competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-20%0%+20%+40%-10%0%+10%+20%PARKHOSPSRHKCVSGBSLJLHLCBAVSPIGDS301293RAINBOWA50AEVSKOVAI301267EXEARDTYATHARTH.NS6-month return →1-month return →
Up and to the right = strong over both horizons. Yatharth Hospital and Trauma Care Services is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%50×100×PARKHOSPSRHKCVSGBSLJLHLCBAVHCG301293RAINBOWAEVSSIAEXEARDTYATHARTH.NSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Yatharth Hospital and Trauma Care Services is the large dot.

Yatharth Hospital and Trauma Care Services competitors and peer comparison

Head to head with its named competitors (YATHARTH.NS vs PARKHOSPS.NS vs MAXHEALTH.NS vs FORTIS.NS)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Yatharth Hospital and Trauma Care Services YATHARTH.NS$1.13B+31%+50%16%49.4×n/a
Park Medi World PARKHOSPS.NS$1.10B-4%+21%21%30.6×22.1%
Max Healthcare Institute MAXHEALTH.NS$10.6B-4%+15%21%55.2×45.3%
Fortis Healthcare FORTIS.NS$6.40B-17%+18%17%48.5×42.5%

How Yatharth Hospital and Trauma Care Services compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Yatharth Hospital and Trauma Care Services against its 20 peers (data as of 18 Nov 2026)
MeasureYATHARTH.NSPeer medianRank in peer set
1-month return+12.4%+1.6%3rd highest of 20
6-month return+31.0%-3.8%2nd highest of 20
Distance from 52-week high-7.8%-21.9%4th highest of 21
Revenue growth (TTM)+50.4%+11.9%highest of 21
Operating margin15.7%10.0%6th highest of 21
Forward P/E49.4×27.1×4th most expensive of 16
ROIC minus cost of capital-5.7 pp-1.8 pp3rd lowest of 21
EV / EBITDA30.9×14.6×2nd most expensive of 16
Net debt / EBITDA0.5×2.6×4th least indebted of 17

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Yatharth Hospital and Trauma Care Services YATHARTH.NSIndia$1.13B+31%+50%16%49.4×n/an/a
Park Medi World PARKHOSPS.NSIndia$1.10B-4%+21%21%30.6×22.1%+10.2%
Rhon-klinikum RHK.DEGermany$1.06B+15%+4%-51%22.5×n/an/a
CVS CVSG.LUnited Kingdom$1.22B+17%+6%11%14.6×14.2%+6.9%
Raffles Medical BSL.SISingapore$1.23B-13%-3%11%27.1×-2.7%+6.1%
Jupiter Life Line Hospitals JLHL.NSIndia$1.01B+9%+17%16%48.8×n/an/a
Clinica Baviera CBAV.MCSpain$1.01B+2%+11%20%20.1×2.3%+19.7%
Spire Healthcare SPI.LUnited Kingdom$1.31B+11%+2%8%25.1×10.0%+11.4%
Ramsay Generale de Sante GDS.PAFrance$969M-25%+3%4%n/a6.1%+6.0%
Paras Healthcare PARASHLTH.NSIndia$962Mn/a+24%11%n/an/an/a
HealthCare Global Enterprises HCG.NSIndia$955M-7%+13%8%88.8×n/an/a
Sanbo Hospital Management 301293.SZChina$1.35B-29%+17%6%135.5×n/an/a
Rainbow Childrens Medicare RAINBOW.NSIndia$1.37B-7%+23%22%40.4×30.7%+21.2%
Thomson Medical A50.SISingapore$923M-18%+6%10%n/a21.2%+11.8%
Aevis Victoria AEVS.SWSwitzerland$1.43B+8%+15%-6%106.8×26.5%+10.2%
Xi'an International Medical Investment 000516.SZChina$1.46B-2%-1%-2%n/a12.7%+20.6%
Sienna Senior Living SIA.TOCanada$1.58B-8%+15%10%40.9×18.9%+8.6%
Kovai Medical Center & Hospital KOVAI.NSIndia$759M+22%+17%21%n/a17.4%+18.1%
Huaxia Eye Hospital 301267.SZChina$1.78B-18%+2%15%23.5×2.1%+10.4%
Extendicare EXE.TOCanada$1.91B-16%+36%9%19.3×10.8%+8.5%
Ardent Health ARDTUnited States$2.03B+52%+2%5%11.9×-1.7%+8.7%

Questions

Who are Yatharth Hospital and Trauma Care Services's main competitors?
Named competitors: Park Medi World (PARKHOSPS.NS), Max Healthcare (MAXHEALTH.NS), Fortis Healthcare (FORTIS.NS). The cockpit's measured peer set (industry) also includes Park Medi World (PARKHOSPS.NS), Rhon-klinikum (RHK.DE), CVS (CVSG.L), Raffles Medical (BSL.SI), Jupiter Life Line Hospitals (JLHL.NS), Clinica Baviera (CBAV.MC).
Is Yatharth Hospital and Trauma Care Services expensive compared with its peers?
On forward p/e it trades at 49.4× against a peer median of 27.1×, 4th most expensive of 16 in its peer set.
How has Yatharth Hospital and Trauma Care Services stock performed?
Over six months to 18 Nov 2026 the shares returned +31.0% against -3.8% for the median peer; over one year +47.4%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.